PTC299 IS A NOVEL DHODH INHIBITOR FOR USE IN TREATMENT OF AML
EHA Library, Marla Weetall, 266621
WHOLE-TRANSCRIPTOME SEQUENCING OF CYTOGENETICALLY NORMAL PEDIATRIC ACUTE MYELOID LEUKEMIA
EHA Library, Lilit Ghukasyan, 266622
SNP ARRAY REVEALS A NEW DELETION OF JAK2 IN AML PATIENTS
EHA Library, Claudio CERCHIONE, 266637
GOOD SENSITIVITY OF ACUTE MYELOID LEUKEMIAS INVOLVING ONLY GRANULOCYTE-MONOCYTE LINE (GM-AML) TO STANDARD-DOSE INDUCTION THERAPY (SICT) IS NOT INFLUENCED BY AGE
EHA Library, Petr Lemez, 266638
UPDATED RESULTS FROM A PHASE 1 STUDY OF GILTERITINIB IN COMBINATION WITH INDUCTION AND CONSOLIDATION CHEMOTHERAPY IN PATIENTS WITH NEWLY DIAGNOSED AML
EHA Library, Alexander Perl, 266653
FINAL REPORT: CLINICAL STUDY OF ORAL ARSENIC TRIOXIDE CAPSULE FORMULATION, ORH-2014, DEMONSTRATING HIGH BIOAVAILABILITY, GOOD SAFETY AND TOLERABILITY IN PATIENTS WITH ADVANCED HEMATOLOGIC DISORDERS
EHA Library, Farhad Ravandi-Kashani, 266654
AGE >70 YEARS, HIGH-RISK CYTOGENETICS, SORROR COMORBIDITY SCORE >1 AND BLAST COUNT>40% IN BM ARE RISK FACTORS FOR INDUCTION FAILURE OF STANDARD CHEMOTHERAPY WITH ANTHRACYCLINE AND CYTARABINE IN AML
EHA Library, Ahmet ELMAAGACLI, 266669
IMPACT OF CYTOMEGALOVIRUS REACTIVATION ON RELAPSE RATE AFTER ALLOGENEIC STEM CELL TRANSPLANTATION IN PATIENTS WITH ACUTE MYELOBLASTIC LEUKEMIA
EHA Library, Nour ben abdeljelil, 266670
SAFETY ANALYSIS OF AUSTRALASIAN LEUKAEMIA & LYMPHOMA GROUP NHL29: A PHASE II STUDY OF IBRUTINIB, RITUXIMAB AND MINI-CHOP IN VERY ELDERLY PATIENTS WITH NEWLY DIAGNOSED DIFFUSE LARGE B CELL LYMPHOMA
EHA Library, Emma Verner, 266685
THE ECHELON-2 TRIAL: RESULTS OF A RANDOMIZED, DOUBLE-BLIND PHASE 3 STUDY OF BRENTUXIMAB VEDOTIN AND CHP (A+CHP) VERSUS CHOP IN FRONTLINE TREATMENT OF PATIENTS WITH CD30+ PERIPHERAL T-CELL LYMPHOMAS
EHA Library, Tim Illidge, 266687
THE INCIDENCE AND CLINICAL IMPACT OF RHOA G17V MUTATION IN ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA PATIENTS
EHA Library, Ya-Ting Hsu, 266703
ESHAP VERSUS GEMOX IN MANAGEMENT OF RELAPSED OR REFRACTORY LYMPHOMA: A PROSPECTIVE RANDOMIZED STUDY
EHA Library, Rasha Salama, 266704
NOVEL COMPOUND HETEROZYGOUS MUTATIONS CAUSING FACTOR XI DEFICIENCY IN UNRELATED TWO CHINESE PATIENTS
EHA Library, Qian Li, 266720
EPIDEMIOLOGICAL STUDY OF IDIOPATHIC THROMBOCYTOPENIC PURPURA AMONG THE ADULT POPULATION OF THE RUSSIAN FEDERATION
EHA Library, Anait Melikyan, 266721
ABSENCE OF GPI-NEGATIVE CELLS AT DIAGNOSIS AND LOW NEUTROPHIL COUNT 2 MONTHS AFTER ATGAM BASED TREATMENT ARE ASSOCIATED WITH LOWER 6-MONTH RESPONSE RATE IN ADULTS WITH (VERY) SEVERE APLASTIC ANEMIA
EHA Library, Jennifer Tjon, 266738
RECURRENT XPO1 MUTATIONS IDENTIFIED AS PREDICTIVE MARKER FOR ADVANCED CLL PROGRESSION
EHA Library, Janek Walker, 266739
COMPLEX STRUCTURAL VARIANTS LEAD TO GENE INACTIVATION RATHER THAN EXPRESSION OF DE NOVO FUSION GENES IN CHRONIC LYMPHOCYTIC LEUKEMIA
EHA Library, Karla Plevova, 266754
TUMOR MUTATIONAL BURDEN ASSESSED BY TARGETED HIGH THROUGHPUT SEQUENCING PREDICTS TREATMENT FREE SURVIVAL IN CLL: RESULTS FROM A BICENTER STUDY
EHA Library, Jasmine Chauzeix, 266755
IMPACT OF COMORBIDITIES ON OUTCOMES OF THERAPY WITH IDELALISIB (IDELA), A PHOSPHOINOTISIDE-3 KINASE-DELTA INHIBITOR, IN RELAPSED OR REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)
EHA Library, Max Gordon, 266770
INFECTIONS IN CLL PATIENTS RECEIVING IBRUTINIB: INCIDENCE AND PREDISPOSING FACTORS
EHA Library, Eugene Nikitin, 266771
CYTOKINE AND ARGINASE-1 EXPRESSION DYNAMICS IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA REVEALS EARLY MOLECULAR RESPONSE TO IMATINIB
EHA Library, Alicia Enrico Mattos, 266786
INFLUX/EFFLUX TRANSPORTERS IN CHRONIC MYELOID LEUKEMIA: THE INFLUENCE OF GENETIC VARIANTS ON SUSCEPTIBILITY AND DRUG RESPONSE
EHA Library, Ana Bela Sarmento-Ribeiro, 266787
FACTORS INFLUENCING PATIENT PREFERENCES FOR DISCONTINUATION OF TYROSINE KINASE INHIBITORS IN CHRONIC MYELOID LEUKEMIA.
EHA Library, Bogdan Ochrem, 266802
CURRENT DOSE RECOMMENDATIONS FOR PONATINIB IN CHRONIC MYELOID LEUKEMIA PATIENTS CAN DIMINISH ADVERSE EVENTS WHILE MAINTAINING EFFICACY
EHA Library, Valentin Garcia-Gutierrez, 266803
: MOLECULAR STUDY OF RED CELL NADH-CYTOCHROME B5 REDUCTASE DEFICIENCY IN 21 INDIAN PATIENTS WITH RECESSIVE HEREDITARY METHEMOGLOBINAEMIA
EHA Library, Prabhakar Kedar, 266818
DIFFERENTIAL DIAGNOSIS OF CONGENITAL HEMOLYTIC ANEMIA OF NEONATES AND INFANTS IN JAPAN
EHA Library, J Howard, 266819
INTRA-BONE DLI AT RELAPSE AFTER ALLO-HSCT IMPROVES SURVIVAL WITH LOWERING OF PD-1 POSITIVITY OF CD8+ CELLS AND PRESERVATION OF THE PROFILE OF TCR BETA DOMINANT CLONES IN THE MARROW
EHA Library, Andrzej Lange, 266834
AUTOLOGOUS DENDRITIC CELL VACCINATION TO PREVENT PROGRESSION AND RELAPSE IN MULTIPLE MYELOMA
EHA Library, Ann VAN DE VELDE, 266835
APPLICATION OF FLOW SOM TO CLASSICAL FLOW CYTOMETRY : UNSUPERVISED ANALYSIS OF HEMATOPOIESIS AND HEMATOLOGICAL MALIGNANCIES.
EHA Library, Marie C Bene, 266851
RED BLOOD CELL GENERATION FROM HUMAN INDUCED PLURIPOTENT STEM CELLS
EHA Library, Emile van den Akker, 266852
CLINICO-BIOLOGICAL CHARACTERISTICS AND TREATMENT OUTCOMES FOR BLASTOID MANTLE CELL LYMPHOMA PATIENTS INCLUDED IN CLINICAL TRIALS. A LYSA STUDY.
EHA Library, Mathieu BALDACINI, 266868
PATIENTS WITH RELAPSED/REFRACTORY INDOLENT NON-HODGKIN LYMPHOMA WERE MORE SENSITIVE TO NEXT TREATMENT FOLLOWING LENALIDOMIDE/RITUXIMAB (R2) THAN RITUXIMAB/PLACEBO (AUGMENT)
EHA Library, John Gribben, 266869
ISAVUCONAZOLE IN HEMATOLOGICAL PATIENTS: FINAL RESULTS OF A REAL-LIFE MULTICENTER SEIFEM (SORVEGLIANZA EPIDEMIOLOGICA DELLE INFEZIONI NELLE EMOPATIE) STUDY
EHA Library, Chiara Cattaneo, 266884
CEFTAZIDIME/AVIBACTAM AND CEFTOLOZANE/TAZOBACTAM FOR THE TREATMENT OF FEBRILE NEUTROPENIA IN ALLOGENEIC TRANSPLANT RECIPIENTS
EHA Library, Daniela Clerici, 266885
CLINICAL IMPLICATIONS OF AZOLE-RESISTANT VERSUS AZOLE-SUSCEPTIBLE INVASIVE ASPERGILLOSIS IN HEMATOLOGICAL MALIGNANCY (CLARITY) - A MULTICENTER STUDY
EHA Library, Danila Seidel, 266900
GLOBAL GUIDELINE FOR THE DIAGNOSIS AND MANAGEMENT OF MUCORMYCOSIS: AN INITIATIVE OF THE ECMM IN COOPERATION WITH THE MSG ERC
EHA Library, Oliver CORNELY, 266901
SOLUBLE TRANSFERRIN RECEPTOR AND ITS FERRITIN INDEX IN COMPARISON WITH BIOCHEMICAL AND HEMATOLOGICAL PARAMETERS FOR THE DIFFERENTIATION OF ANEMIA STATES AND CORRELATION WITH IV IRON RESPONSE
EHA Library, Nina Petkova, 266916
A NURSE LED IRON INFUSION CLINIC REDUCES POTENTIAL PATIENT HARM AND IMPROVES HOSPITAL EFFICIENCY
EHA Library, Laurie Newman, 266917
CHANGES IN THE SECRETOME COMPOSITION OF MULTIPOTENT MESENCHYMAL STROMAL CELLS PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA WITHOUT BONE MARROW INVOLVEMENT
EHA Library, Nataliya Petinati, 266932
UNFOLDED PROTEIN RESPONSE AFTER TREATMENT WITH 2-DEOXYGLUCOSE CREATES SUBSTANTIAL SYNERGY WITH IMMUNOTOXIN MOXETUMOMAB PASUDOTOX IN B-CELL LYMPHOMA AND LEUKEMIA XENOGRAFTS.
EHA Library, Fabian Müller, 266933
MYELOMONOCYTIC SKEWING IN CHRONIC MYELOMONOCYTIC LEUKEMIA: PHENOTYPIC, GENOTYPIC AND BIOLOGIC FEATURES AND IMPACT ON SURVIVAL
EHA Library, Klaus Geissler, 266948
RIGOSERTIB MODULATES HEMATOPOIESIS GENE SIGNALING PATHWAYS ALONE OR IN SEQUENCED COMBINATION WITH AZACTIDINE ON MDS CELLS IN VITRO.
EHA Library, Lewis SILVERMAN, 266949
PHF19 INDUCES EZH2 PHOSPHORYLATION AND PROMOTES DRUG RESISTANCE IN MULTIPLE MYELOMA
EHA Library, Chen-Xing Du, 266964
DETAILED PHENOTYPIC, MOLECULAR AND FUNCTIONAL PROFILING OF MYELOID DERIVED SUPPRESSOR CELLS (MDSCS) IN THE TUMOR IMMUNE MICRO-ENVIRONMENT (TIME) OF MULTIPLE MYELOMA (MM)
EHA Library, Cristina Pérez Ruiz, 266965
EXOSOMAL CARGO IN MONOCLONAL GAMMOPATHIES COMPARED TO HEALTHY DONORS AND ITS POTENTIAL RELATION TO MYELOMA AGGRESSIVENESS.
EHA Library, Bruna Ferreira, 266981
NEXT-GENERATION OPTICAL MAPPING REVEALS LARGE GENETIC HETEROGENEITY IN MULTIPLE MYELOMA
EHA Library, Anna PETRACKOVA, 266982
TISSUE ENGINEERING OF AN ORTHOTOPIC HUMANIZED BONE-ORGAN AS A PLATFORM FOR PRECLINICAL MULTIPLE MYELOMA RESEARCH
EHA Library, Alvaro Sanchez, 266983
PEPTIDE VACCINATION AGAINST PD-L1 (IO103) IN MULTIPLE MYELOMA - A PHASE I FIRST IN HUMAN TRIAL
EHA Library, Nicolai Jørgensen, 266997
A PHASE 2 TRIAL OF THE COMBINATION OF IXAZOMIB, THALIDOMIDE AND DEXAMETHASONE (ITD) IN RELAPSED AND/OR REFRACTORY MULTIPLE MYELOMA - THE AMARC 16-02 TRIAL
EHA Library, Andrew Spencer, 266998
DEEPENING RESPONSES SEEN WITH IXAZOMIB MAINTENANCE POST-AUTOLOGOUS STEM CELL TRANSPLANTATION (ASCT) ARE ASSOCIATED WITH PROLONGED PROGRESSION-FREE SURVIVAL - ANALYSIS FROM THE TOURMALINE-MM3 STUDY
EHA Library, Hartmut Goldschmidt, 266999
RESULTS OF PHASE I/II STUDY OF NIVOLUMAB WITH AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION IN MULTIPLE MYELOMA PATIENTS WITH SUBOPTIMAL RESPONSE TO PRIMARY INDUCTION THERAPY
EHA Library, Olga PIROGOVA, 267013
OUTCOMES OF LONG-TERM SURVIVORS WITH ACTIVE MULTIPLE MYELOMA
EHA Library, Brett Grieb, 267014
RECOVERY OF POLICLONAL IMMUNOGLOBULINS AS A PREDICTOR FACTOR OF INCREASED PROGRESSION-FREE SURVIVAL AND OVERALL SURVIVAL IN PATIENTS WITH MULTIPLE MYELOMA INELIGIBLE FOR ASCT
EHA Library, Julio Davila Valls, 267015
POMALIDOMIDE 3RD LINE VERSUS 4TH LINE FOR IN EARLY RELAPSED REFRACTORY MULTIPLE MYELOMA
EHA Library, Cecile Gruchet, 267029
INCIDENCE OF NEGATIVE MINIMAL RESIDUAL DISEASE IN MULTIPLE MYELOMA PATIENTS AFTER AUTOLOGOUS STEM CELL TRANSPLANT
EHA Library, Carolina Afonso, 267030
A PHASE 1B/2 STUDY OF SELINEXOR, CARFILZOMIB, AND DEXAMETHASONE (SKD) IN RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM)
EHA Library, Cristina J. Gasparetto, 267031
GCSF ALONE STEM CELL MOBILIZATION IN MULTIPLE MYELOMA PATIENTS CANDIDATES TO HIGH DOSE CHEMOTHERAPY: A MONOCENTRIC RETROSPECTIVE EXPERIENCE.
EHA Library, Stefania Bramanti, 267045
LIVING ALONE WITH MULTIPLE MYELOMA: THE NEXT-GENERATION CHALLENGE
EHA Library, Rafael Ríos-Tamayo, 267046
INTEGRATION OF FOUR COLOUR FLOW TO PREDICT RELAPSE/PROGRESSION AND TIME TO NEXT TREATMENT IN MULTIPLE MYELOMA AFTER UPFRONT AUTOLOGOUS STEM CELL TRANSPLANT
EHA Library, Pedro Miguel Aparício Chorão, 267047
THE ROLE OF THE THROMBOPOIETIN RECEPTOR (MPL) IN JAK2V617F-POSITIVE MYELOPLROLIFERATIVE NEOPLASMS
EHA Library, Kira Behrens, 267063
ANALYSIS OF UPR-RELATED GENE EXPRESSION IN CD34+ CELLS FROM PATIENTS WITH PRIMARY MYELOFIBROSIS REVEALS DOWNREGULATION OF UPR GENES AND REDUCTION OF APOPTOSIS
EHA Library, Paolo Catarsi, 267064
FAMILIAL OCCURRENCE OF SYSTEMIC AND CUTANEOUS MASTOCYTOSIS IN AN ADULT MULTICENTER SERIES: A REPORT OF 22 CLUSTERED CASES
EHA Library, Ilaria Tanasi, 267078
SECOND PRIMARY MALIGNANCIES IN MYELOFIBROSIS PATIENTS TREATED WITH RUXOLITINIB: REAL WORLD EVIDENCE FROM 215 CONSECUTIVELY TREATED PATIENTS IN LOMBARDY
EHA Library, Margherita MAFFIOLI, 267079
SURVIVAL OUTCOMES IN MYELOFIBROSIS PATIENTS TREATED WITH RUXOLITINIB: A POPULATION-BASED COHORT STUDY IN SWEDEN AND NORWAY
EHA Library, Frida Schain, 267080
PLATELET DISFUNCTION IN NOONAN AND 22Q11.2 DELETION SYNDROMES IN CHILDHOOD
EHA Library, Albert CATALA, 267094
EVALUATION OF COMBINED MEASUREMENT OF IMMATURE PLATELET FRACTION AND SCHISTOCYTES IN PREGNANCY-ASSOCIATED THROMBOTIC THROMBOCYTOPENIC PURPURA AND SEVERE PREECLAMPSIA/ HELLP SYNDROME
EHA Library, Rasha El-Gamal, 267095
INTERLEUKIN-37 REDUCES INFLAMMATION AND IMPAIRS PHAGOCYTOSIS OF PLATELETS IN IMMUNE THROMBOCYTOPENIA
EHA Library, Yajing Zhao, 267097
FUNCTIONAL ASSAYS USING WASHED PLATELETS FOR HEPARIN-INDUCED THROMBOCYTOPENIA DIAGNOSIS: A RETROSPECTIVE STUDY COMPARING HEPARIN- INDUCED PLATELET ACTIVATION TEST VERSUS 14C-SEROTONIN RELEASE ASSAY
EHA Library, Vasiliki Gkalea, 267112
ANKRD26-RELATED THROMBOCYTOPENIA: STUDY OF 3 FAMILIES
EHA Library, Daniela Sofia Coelho, 267113
NEUTROPHIL EXTRACELLULAR TRAPS (NETS), BLOOD CELL COUNTS AND THROMBOTIC RISK IN ITP PATIENTS
EHA Library, Maria Lozano, 267114
THE FINANCIAL IMPACT OF ACUTE LEUKAEMIA
EHA Library, Charlotte Martin, 267128
THE DIAGNOSTIC YIELD OF BONE MARROW BIOPSY IN PATIENTS WITH LIVER FAILURE
EHA Library, Thinzar Ko Ko, 267129
ESTIMATING LIFE-YEAR LOSS OF PRIMARY MYELOFIBROSIS IN EUROPE
EHA Library, Zhiyi Li, 267130
HYDROXYUREA ESCALATED TO MAXIMAL TOLERATED DOSE IN CHILDREN WITH SICKLE CELL ANEMIA AND BCL11A: BENEFITS FOR END-ORGAN DAMAGE AND ACUTE COMPLICATIONS UP TO 6 YEARS OF AGE
EHA Library, Jeremie Estepp, 267144
INCREASED T CELLS GLYCOLYSIS IN PATIENTS WITH ACUTE GRAFT VERSUS HOST DISEASE AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL
EHA Library, Yang Song, 267145
CROSSTALK AMONG COMPLEMENT, COAGULATION AND NEUTROPHILS IN TRANSPLANT-ASSOCIATED THROMBOTIC MICROANGIOPATHY
EHA Library, Eleni Gavriilaki, 267146
RELIEVING IMMUNOSUPPRESSION IMPROVES VΔ2+ T CELLS RECOVERY AND DECREASES EBV REACTIVATION AFTER HEMATOPOIETIC TRANSPLANTATION
EHA Library, Haitao Gao, 267160
IMPACT OF MOLECULAR RESPONSE ON SURVIVAL AMONG ALLOGENEIC STEM CELL TRANSPLANTATION RECIPIENTS WITH B-LYMPHOBLASTIC LEUKAEMIA WITH BCR-ABL1.
EHA Library, Siew Lian Chong, 267162
IS IT BETTER TO MOBILIZE HEMATOPOIETIC STEM CELLS FROM HEALTHY DONORS AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION WITH PEGFILGRASTIM?
EHA Library, Cheng ZHANG, 267163
RITUXIMAB-BEAM AND AUTOLOGOUS STEM CELL TRANSPLANT (ASCT) FOR PATIENTS (PTS) WITH RELAPSED FOLLICULAR LYMPHOMA (FL) NOT ABLE TO RECEIVE AN ALLOGENEIC SCT: 8-YEAR MEDIAN FOLLOW-UP RESULTS.
EHA Library, Issa Khouri, 267178
IDENTIFYING RELATIONSHIP BETWEEN HEREDITARY PREDISPOSITION GENE AND COMPLICATIONS AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION IN ACUTE LEUKEMIA
EHA Library, Zhihui LI, 267179
POST-TRANSPLANTATION CYCLOPHOSPHAMIDE VS. ANTITHYMOCYTE GLOBULIN AS GVHD PROPHYLAXIS FOR MISMATCHED UNRELATED HEMATOPOIETIC STEM CELL TRANSPLANTATION
EHA Library, Charlotte Nykolyszyn, 267180
PLATELET COUNT AND MEAN PLATELET VOLUME IN ACUTE STROKE: A SYSTEMATIC REVIEW AND META-ANALYSIS
EHA Library, Houshang Amir SHEMIRANI, 267194
EPIDEMIOLOGY AND RISK ASSESSMENT OF PEDIATRIC VENOUS THROMBOEMBOLISM IN KOREA
EHA Library, Jae Min LEE, 267195
AN EPIDEMIOLOGIC STUDY OF PREGNANCY RELATED VENOUS THROMBO-EMBOLISM IN SOUTH AFRICA: ARE HIV INFECTED WOMEN A NEW HIGH-RISK GROUP?
EHA Library, Elise schapkaitz, 267196
AIHA IN HEMATOLOGICAL DISEASES - CHALLENGES FOR IMMUNOCHEMATOLOGY AND RISK-MANAGEMENT OF TRANSFUSION THERAPY
EHA Library, Yonka Lazarova, 267210
EXPERIENCE WITH THE NEUTRALIZING AGENT DARAEX® IN BLOOD COMPATIBILITY TESTS IN PATIENTS TREATED WITH DARATUMUMAB
EHA Library, Almudena Garcia Ruiz, 267211
PREVENTING ALLOIMMUNIZATION OF RECIPIENTS WITH SELECTING OF DONORS BY RED BLOOD CELLS ANTIGENS OF THE RHESUS SYSTEM
EHA Library, Elena Butina, 267212
LMO2-INDUCED MURINE T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA FREQUENTLY EVOLVES TO ONCOGENE INDEPENDENCE
EHA Library, Matthew McCormack, 267226
IN VITRO AND IN VIVO STUDIES OF NOVEL ASPARAGINASE MUTANTS FOR THE TREATMENT OF ACUTE LYMPHATIC LEUKEMIA
EHA Library, Soumika Sengupta, 267227
PHOSPHOCHROMATOME ANALYSIS UNCOVERS UNEXPECTED ROLES OF CDK6 IN REGULATING TRANSCRIPTION
EHA Library, Sofie Nebenfuehr, 267228
SAFETY AND EFFICACY OF TISAGENLECLEUCEL (CTL019) IN B ACUTE LYMPHOBLASTIC LEUKEMIA IN CHILDREN AND YOUNG ADULTS: ROBERT DEBRÉ AND SAINT LOUIS HOSPITALS EXPERIENCE
EHA Library, Andre Baruchel, 267244
LONG-TERM OUTCOME OF ALLOGENEIC-HCT IN ADULT PATIENTS WITH ALL IN FIRST REMISSION; FAVORABLE GVHD-AND-RELAPSE-FREE SURVIVAL OF DOUBLE CORD BLOOD TRANSPLANTATION COMPARED TO CONVENTIONAL DONOR TYPES
EHA Library, Joonyeop Lee, 267245
KTE-X19, AN ANTI-CD19 CHIMERIC ANTIGEN RECEPTOR T CELL THERAPY, IN ADULT PATIENTS WITH RELAPSED/REFRACTORY ACUTE LYMPHOBLASTIC LEUKEMIA: END OF PHASE 1 RESULTS OF ZUMA-3
EHA Library, Bijal D. Shah, 267246
MVP COMBINED WITH FC AS LYMPHOCYTE-DEPLETING CHEMOTHERAPY BEFORE CAR-T TREATMENT CAN REDUCE THE INCIDENCE OF SEVERE CYTOKINE RELEASE SYNDROME FOR R/R ALL PATIENTS WITH HIGH TUMOUR BURDEN
EHA Library, Xiaowen Tang, 267260
BLINATUMOMAB - BASED THERAPIES IN CHILDREN AND ADULTS WITH MRD+ AND R/R B-ALL, EXPERIENCE FROM A SINGLE CENTER (CIC 725)
EHA Library, Inna Markova, 267261
HIGH-RESOLUTION CLONAL ANALYSIS OF TUMORS WITH SIMULTANEOUS SINGLE-CELL DNA SEQUENCING AND CELL SURFACE PHENOTYPING
EHA Library, G Fuerte, 267276
METABOLIC REPROGRAMMING OF ACUTE MYELOID LEUKEMIA STEM- PROGENITOR CELLS AT RELAPSE
EHA Library, Martina Ghetti, 267277
DE NOVO ADULT ACUTE MYELOID LEUKEMIA PATIENTS DISPLAY AT DIAGNOSIS FUNCTIONAL DEREGULATION OF REDOX BALANCE CORRELATED WITH MOLECULAR SUBTYPES AND OVERALL SURVIVAL
EHA Library, Julie Mondet, 267294
OLIGOMONOCYTIC CHRONIC MYELOMONOCYTIC LEUKEMIA (O-CMML) SHARES IMMUNOPHENOTYPIC AND MOLECULAR CHARACTERISTICS WITH CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML)
EHA Library, Xavier Calvo, 267295

Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.


Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.



Google Analytics is used for user behavior tracking/reporting. Google Analytics works in parallel and independently from MLG’s features. Google Analytics relies on cookies and these cookies can be used by Google to track users across different platforms/services.


Save Settings